Bexa

Name

Bexa

Legal name

Bexa, Inc.

Website

https://mybexa.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Breast Cancer Early Detection Services

NAICS

Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Mammography & Breast Imaging Systems (HLAHABAF)

akta.pro secondary industry

Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD)

Keywords

• Breast cancer screening
• Pressure mapping diagnostics
• Preventive health services
• Employer health benefits
• Clinical breast examination

Headquarters

HQ city

Rolling Hills Estates

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Per-use employer-paid breast exams (B2B): Primary revenue stream. Self-funded employers (and the State of Texas, State of Florida, BCBS Texas) pay for Bexa Breast Exams as a covered preventive service through their ASO providers or TPAs (11 TPAs as of source). Billed per use (not PEPM), typically via 'bulk' or 'batch' billing. Reported as 65% less expensive than mammograms.
2. Non-profit / Alliance grant and donor funding: Funding from grants (e.g., State of Texas grant for ABHT) and individual/corporate donations supports Alliance programs (Access to Breast Health for Texans, Bexa for Cowgirls, Bexa Equity Alliance). 100% of received funds are stated as going to examiner costs (salary & supplies).
3. International country programs (UAE, Saudi Arabia, LATAM, Indonesia): Country-based subsidiaries and partnerships (with Emirates Health Service, governments of Dubai & Abu Dhabi, telecom providers, etc.) deliver Bexa Programs to worksites, community sites, and retail sites internationally. Indonesia is also a manufacturing center for Bexa device components.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Bexa provides the Bexa Breast Exam (BBE), a 30-minute on-site breast cancer early detection service that combines a clinical breast exam, the proprietary FDA 510(k)-cleared (K181672) Bexa Pressure Mapping System (a wireless sensor array with AI-driven tissue elasticity mapping), and a Clarius handheld ultrasound read by US-based, fellowship-trained breast radiologists. The exam is delivered at employer workplaces as a covered preventive service, billed per use to self-funded employer health plans through ASO providers and 11 TPAs, and is described as costing 65% less than mammograms.

Product overview

Bexa offers a single unified breast cancer early-detection offering built around one core product — the Bexa Breast Exam (BBE) — that combines a clinical exam, the proprietary Bexa Pressure Mapping System (a hardware medical device), and a handheld ultrasound (Clarius). The MyBexa system supports patient registration/portal workflows, while the Bexa Programs umbrella distributes the BBE through corporate/employer channels and Bexa Analytics Team services support breast cancer analytics work. Internationally, Bexa runs regional distribution arms (Bexa UAE, Bexa Saudi Arabia, Bexa LATAM, Bexa Indonesia), and its non-profit arm operates the Access to Breast Health for Texans (ABHT) program, Bexa for Cowgirls, and the Bexa Equity Alliance (BEA). The Bexa Device received FDA 510(k) clearance (K181672).

Differentiator

Problem solved

Functional benefit

Brands

• Bexa UAE: Dubai-based regional screening program providing Bexa Breast Exams to women 25+ in partnership with the Emirates Health Service and the governments of Dubai and Abu Dhabi.
• Bexa Saudi Arabia
• Bexa LATAM
• Bexa Indonesia
• Bexa Assurance
• Bexa Equity Alliance
• Access to Breast Health for Texans (ABHT)
• Bexa for Cowgirls

Products and services

• Bexa Breast Exam (BBE) The flagship breast cancer early detection service that combines a clinical breast exam, the proprietary FDA 510(k)-cleared Bexa Pressure Mapping System (AI-driven surface pressure map of tissue elasticity), and a Clarius handheld ultrasound in a single on-site workflow; delivers results at the time of the exam for ~95% of women and radiologist interpretation within 24-48 hours for the rest; designed for self-funded employers as a covered preventive service.
• Bexa Pressure Mapping System (Bexa Device) Proprietary medical device (FDA 510(k) cleared, K181672) that uses an array of high-speed pressure sensors (>20,000 samples/second) and AI to produce a surface pressure map identifying areas of suspicious tissue stiffness; available exclusively as part of the Bexa Breast Exam.
• MyBexa Patient Portal and Registration System Online patient registration and portal that supports the Bexa Breast Exam workflow, distributes results, and hosts the Tyrer Cuzick personal breast cancer risk assessment questionnaire.
• Bexa Programs Employer-facing program that delivers the Bexa Breast Exam through workplaces and partner organizations as a covered employee preventive health benefit, including promotion support, on-site examiners and supplies, and program reporting; deployed across 200+ clients and 450+ sites in the U.S. and internationally.
• Bexa Analytics Team In-house analytics function that performs claims-data analysis of breast cancer screening participation, cost, and performance using data fed by 200+ Bexa clients.

Quantifiable outcome

• 65% less expensive than mammograms; billed per use rather than PEPM
• +7 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Clarius (handheld ultrasound)coreTechnology or IntegrationClarius handheld ultrasound technology is integrated into every Bexa Breast Exam as the final imaging step. Bexa examiners use the Clarius device to localize and characterize masses identified via the Bexa Pressure Map, with images interpreted by US-based, licensed, fellowship-trained breast radiologists within 24-48 hours.
• BCBS Texas (Blue Cross Blue Shield of Texas)coreChannel Partner/ Reseller/ DistributorBCBS Texas will now pay for Bexa Breast Exams as a normal individual claim, enabling direct claim-based reimbursement for self-funded customers. This is a key distribution enabler for Bexa's per-use, employer-paid model.
• 11 Third Party Administrators (TPAs) and all ASO providerscoreChannel Partner/ Reseller/ DistributorBexa Breast Exams are paid for by health plans administered by all ASO providers and 11 TPAs when the plan sponsor directs. Self-funded customers direct their ASO or TPA provider to pay for exams, most commonly as a 'bulk' or 'batch' bill.
• Laura Bush Institute for Women's Health / Texas Tech University Health Sciences Center (ABHT)coreStrategic or Co-development PartnerFunded by a State of Texas grant and operated in partnership with the Laura Bush Institute for Women's Health at Texas Tech University Health Sciences Center, ABHT delivers Bexa exams to women in rural Texas communities from churches, community centers, etc. Reported >95% adoption and near 100% follow-through with secondary imaging; tripling in size in 2026 to serve the Permian Basin, Big Country, and south/east Texas.
• National Cutting Horse Association, Clarke Butte Ranch, Morgan Cromer Cutting Horses, Lindy Burch, Multiple Private Companies and Individuals (Bexa for Cowgirls)minorGTM or Marketing PartnerBexa for Cowgirls is supported by the Western equine competition community (rodeo, PBR, NFR, weekend shows) and corporate sponsors profiting from the equine industry, providing Bexa Breast Exams to female trainers and young women who manage, exercise, and care for horses and typically have low wages and no benefits.
• National Collection of Minority Breast Cancer Advocacy Groups (Bexa Equity Alliance)coreStrategic or Co-development PartnerThe Bexa Equity Alliance (BEA) works in partnership with local and national minority breast cancer advocacy groups to demonstrate that Bexa Breast Exams are >95% adopted among African American women of all demographics and geographies and can address the younger average age of onset by initiating annual early detection at age 35.
• Emirates Health Service and Governments of Dubai & Abu Dhabi (Bexa UAE)coreStrategic or Co-development PartnerPartnership to deliver the first large-scale screening program fitted to the demographics of breast cancer in a population. Bexa UAE offers Bexa breast exams to women 25+ across the Emirates, acknowledging that Arab women are diagnosed on average 10 years younger than Western women. Based in Dubai, expanding across the Emirates. Site: bexassurance.com.
• Colombia's largest telecom provider (Bexa LATAM)coreChannel Partner/ Reseller/ DistributorInnovative partnership giving Bexa LATAM distribution into retail, worksite, and community programs across Colombia, with operations expanding into Ecuador and Peru. Combined with insurance company partnerships.
• Colombia's leading breast surgeon and imaging group (Bexa Colombia clinical research)coreStrategic or Co-development PartnerBexa Colombia operates as an active clinical research hub for Bexa, Inc., partnering with Colombia's leading breast surgeon and imaging group to continue defining the performance of the Bexa device, the Bexa Process, and exploring the ability of community health workers to successfully perform focused ultrasound of breast abnormalities.
• Dr. Jae Son (Bexa technology co-creator)coreStrategic or Co-development PartnerCo-created the Bexa Pressure Mapping System technology over more than 10 years alongside current Chief Technology Officer David Ables.
• The Beautiful Way FoundationminorGTM or Marketing PartnerThe Beautiful Way Foundation hosted its second annual Community Power Expo and Convergence Summit in Boston; Bexa / Bexa Equity Alliance is associated with this community outreach event.
• Cosmetic, clothing, fitness, food, and lifestyle brand partners (recruiting)minorGTM or Marketing PartnerBexa is actively recruiting new, non-medical brand partnerships from cosmetic, clothing, fitness, food, and related lifestyle industries to surround Bexa Breast Exams with a 'mental space' that further softens the experience and to leverage the 'Angelina Effect' cause-marketing power of breast cancer as a brand affiliation.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Others

• Clarius Mobile Health: Maker of the Clarius handheld ultrasound scanner integrated into every Bexa Breast Exam. Functions as a key technology supplier; also sells directly into the same point-of-care breast imaging market that Bexa serves.

Direct peers

• Delphinus Medical Technologies: Developer of SoftVue, a 3D whole-breast ultrasound tomography system FDA-cleared as an adjunct to mammography for women with dense breast tissue. Most directly comparable to Bexa's approach of using an alternative imaging modality to close the dense-breast / under-40 screening gap.
• iCAD: AI-driven breast cancer detection and risk-stratification software used alongside mammography (e.g., ProFound AI). Competes for the same breast-imaging AI workflow budgets and the same employer/payer screening-quality narrative.
• Volpara Health: Provides AI-based breast density assessment and risk-stratification analytics to mammography providers. Overlaps with Bexa's analytics team offering and dense-breast positioning.

Emerging players

• CureMetrix: AI-based mammography computer-aided detection (cmAssist, cmTriage) for radiologists. Adjacent in the AI breast-iming space with narrower deployment focus than Bexa's employer-paid model.
• Therapixel: Developer of MammoScreen, an AI-based mammography decision-support tool (FDA-cleared). Competes for breast-imaging AI budget and clinical workflow integration.
• Densitas: AI-driven breast density and image quality analytics integrated into mammography workflows. Closely comparable on the analytics-as-a-service angle to Bexa's Bexa Analytics Team.

Broad incumbents

• Hologic: Dominant incumbent in mammography (3Dimensions, Genius AI) and a broad women's-health portfolio. Sets the standard-of-care against which Bexa positions and controls the dominant installed base that any alternative screening modality must displace.
• GE HealthCare: Sells mammography systems (Pristina), ultrasound, and AI imaging tools across the full breast-imaging workflow. Competes for the same hospital/employer budgets as part of a much broader portfolio.
• Siemens Healthineers: Mammography, ultrasound, and AI-breast-imaging offerings (e.g., MAMMOMAT, AI-Rad Companion) sold to large health systems globally. Provides an indirect incumbent threat via integrated procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/bexaequityalliance
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/bexa

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bexa